Timothy T Goodnow has bought SENS on 3 days since Sep 2019

Timothy T. Goodnow, PhD is the President and Chief Executive Officer of Senseonics Holdings, Inc., a role he has held since December 2015, after joining the board in December 2010 and becoming President & CEO in March 2011.( Under his leadership, Senseonics has commercialized the Eversense continuous glucose monitoring (CGM) systems, including the first 90-day product in Europe, the 180-day Eversense XL distributed in over 15 countries, and a rapid U.S. launch just 40 days after FDA approval.(

Goodnow brings extensive experience in medical device development, particularly in diabetes care. Prior to Senseonics, he served as Divisional Vice President of Technical Operations at Abbott Diabetes Care (2000-2011), Vice President of R&D at TheraSense (2000-2004), Founder and VP of R&D at Verax Biomedical (1998-2000), and held executive roles at Baxter Healthcare and Dade Behring.( He earned his PhD and BS in Chemistry from the University of Miami.(

Written by Perplexity from public sources.